Proxy Firm OKs Poison Pills, Bashes Buybacks In Pandemic
Short-term poison pills may be a reasonable response to coronavirus-related stock drops, but companies should be extremely wary about share repurchases during the pandemic, Institutional Shareholder Services Inc. said in releasing...To view the full article, register now.
Already a subscriber? Click here to view full article